Serum plasmalogens (1-O-alk-1-enyl-2-acyl glycerophospholipids; Pls) are of particular interest for studies on metabolic disorders associated with oxidative stress and chronic inflammation. Serum levels of Pls are known to correlate positively with HDL-cholesterol (HDL-C); however, few studies have examined serum Pls molecular species in association with pathophysiological conditions and their clinical significance.
as cardiac muscle and blood plasma, whereas the latter belong to a predominant class distributed in a wide variety of cells and tissues (1) . Serum Pls levels are associated with diverse clinical manifestations (2) . For instance, some patients with peroxisomal disorders were found to exhibit the systemic reduction of Pls, which was explained by the fact that the first two steps of Pls biosynthesis occur exclusively in peroxisomes (3) . In addition, since Pls are abundant in the brain and play essential roles in neuronal functions and myelin formation, defects in Pls contents represent a pathological factor for a number of neurodegenerative disorders such as Alzheimer's disease (AD) (4). Goodenowe et al. also reported that the serum level of PlsEtn containing docosahexaenoic acid (DHA; 22:6) could be a useful biomarker for the early detection and long-term follow-up of AD (5) .
by guest, on www.jlr.org Downloaded from 8 Recently, particular attention has been paid to the involvement of Pls in metabolic diseases associated with oxidative stress and chronic inflammation (6) .
Plasmalogens may be involved in the etiology of both type 1 and type 2 diabetes mellitus (T1D and T2D, respectively) through oxidative stress. Patients with T1D exhibit absolute insulin deficiency due to autoimmune destruction of insulin producing pancreatic β-cells. In a longitudinal study, children who develop T1D later have been found to have reduced serum levels of ether type choline glycerophospholipids, including PlsCho at birth and consistently throughout medical follow-ups (7) .
Plasmalogen deficiency may cause enhanced susceptibility of pancreatic β cells to oxidative damage and trigger progression to diabetes. Oxidative stress may also be associated with T2D and related cardiovascular diseases. Notable decreased PlsEtn levels and increased lipid peroxidation were found in LDL particles from obese patients with metabolic syndrome (MetS) and patients with T2D (8) , which may be a risk factor for atherosclerosis. Plasma Pls may be a good marker for inferring level of oxidative stress and predicting cardiovascular mortality in patients with end-stage renal disease (9) . Plasma concentration of Pls also decreases with hypertension (10) as well as age and chronic inflammatory-related diseases such as atherosclerosis and AD (11, 12) . Plasmalogens function as reservoirs for precursor fatty acids, such as To date, however, available data regarding the relationship between serum Pls and clinical disease entities are still limited, and the association of Pls molecular species with preclinical pathophysiological conditions is yet to be clarified. Previously, we performed an advanced comprehensive analysis of serum ether glycerophospholipids, including Pls, by LC/MS/MS, which has allowed the accurate quantification of each molecular species (16, 17) . The present study provides the reference data from 428 Japanese asymptomatic subjects on their serum levels of individual ether glycerophospholipid species. By analyzing the correlation of each molecular species with clinical parameters or biochemical measurements, we found that PlsCho with 18:1 in the sn-2 position strongly correlated with a wide range of risk factors for atherosclerosis and MetS. Our finding suggests that serum PlsCho, like HDL-C, may serve as a sensitive antiatherogenic biomarker. 
METHODS

Study subjects and design
Asymptomatic subjects (n = 428; 362 male and 66 female subjects; age, 22-66 years old) who were referred for a routine health examination were enrolled in the study. Written informed consent was obtained from all participants, and the studies were approved by the ethics committees of Hokkaido University, Teikyo University School of Medicine, and ADEKA Co., Ltd. Sera were separated from fasting blood in a blood collection tube containing coagulation accelerating agent by centrifugation at 1,500  g for 10 min, and then an antioxidant was added (dibutylhydroxytoluene; BHT, final concentration of 10 µM) and metal chelator (ethylenediaminetetraacetic acid; EDTA, final concentration of 1 mM), followed by immediate freezing at -80°C until analysis. Measurements of body weight, stature, waist circumference, and blood pressure were recorded. Participants were asked to complete health questionnaires consisting of 24 questions with regard to their medical history, as well as their dietary, smoking, drinking, and exercise habits. 
Measurement of ether glycerophospholipids
Serum lipids were extracted by chloroform/methanol (1:2, v/v) after the serum was freeze-dried. Briefly, 1 mL of methanol, including internal standards (1,2-dimyristoyl-phosphatidylcholine; DMPC and phosphatidylethanolamine; DMPE) and BHT, was added to the freeze-dried serum (100 μL) and shaken for 30 sec. Then, 0.5 mL of chloroform was added to each tube and shaken for 30 sec. After letting the tube stand at room temperature for 30 min, the tubes were shaken, centrifuged, and the chloroform/methanol layer was harvested. This procedure was repeated three times, and the collected chloroform/methanol layer was evaporated until dry. The dried samples, including extracted lipids, were dissolved with methanol. Ether glycerophospholipids, including Pls, in extracted lipids were analyzed by LC/MS/MS. 
Condition of LC/MS/MS
Liquid chromatography-tandem mass spectrometry was conducted following a slightly modified method described previously (16) . Liquid chromatography separation was performed using an Accela UPLC system (Thermo Fisher Scientific Inc., Waltham, MA, USA) with a BEH C8 column (1.7 µm, 100 mm  2.1 mm i.d.; 
Biochemical analysis
Serum concentrations of TG, HDL-C, LDL-C, total phospholipids (PL), blood glucose, uric acid (UA), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transpeptidase (-GTP) were determined enzymatically with an AutoAnalyzer (JCA-BM8060; JEOL, Ltd, Tokyo, Japan) and reagent kits (Wako Pure Chemical Industries, Ltd, Osaka, Japan). Small dense low-density lipoprotein cholesterol was measured using the sdLDL-EX "Seiken" Kit (Denka Seiken, Tokyo, Japan). High-sensitivity C-reactive protein (hsCRP) was quantified by a latex photometric immunoassay (LPIA ACE CRP-H II; Mitsubishi Chemical Medience Corp).
Homocysteine (Hcy) was measured enzymatically using the Alfresa Auto Hcy Kit (Alfresa Pharma Corp., Osaka, Japan). Total adiponectin was determined using a sandwich ELISA system (Adiponectin ELISA Kit; Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan).
Statistical analysis
Statistical analysis was performed using Excel (2010; Microsoft Corporation, Redmond, WA) with the add-in software Statcel 3 (OMS, Tokyo, Japan). Data are presented as mean  SD or median and interquartile range. Results were analyzed by Tukey-Kramer post-hoc tests for parametric data (Supplemental Table III) , and Steel-Dwass (Table 1, Supplemental Tables III, IV , and V) as well as Mann-Whitney U tests (Table 1, Supplemental Tables III, IV , V, and VI) for non-parametric data.
Correlations among measurements were assessed with Spearman's rank tests 
Background of asymptomatic subjects
Clinical parameters and serum biochemical measurements of the subjects were classified by age (under 39 or over 40 years old) and gender (Supplemental Table III ). The data indicate that male subjects over 40 years old (≥40) exhibited various abnormalities in clinical and biochemical parameters, including waist circumference, blood systolic and diastolic pressures (s.p. and d.p.), blood glucose, the serum levels of UA, AST, ALT, -GTP, and TG, as well as the atherogenic index of plasma (AIP, calculated as log (TG/HDL-C)). To confirm that these ≥40 year old subjects belonged to the population at risk, serum concentrations of sdLDL, hsCRP, Hcy, and adiponectin were determined. The data of certain male subjects ≥40 indicated that they were near the upper or lower limit of a normal serum range, suggesting that male subjects over 40 years old are associated with proatherogenic status (Supplemental Table III ).
Characteristics of serum ether glycerophospholipids
The serum concentrations of each class of Pls, i.e., PlsCho and PlsEtn, as Table 1) . The results show that while the serum levels of PlsCho and PlsEtn were almost equal, the serum concentrations of PakEtn were much lower than those of PakCho. In addition, the PlsCho/PL ratio for the ≥40 male group was significantly lower than those for other groups, whereas the PlsCho/PlsEtn ratio and Total Pls/PL (mol%) were higher among the under 39 year old (≤39) female and ≥40 female groups, respectively ( Table 1 ). The statistical comparisons of age groups were adjusted by confounding factors such as diet, smoking, drinking, and exercise. Although the significant differences in some of these confounding factors were observed among age groups, these confounding factors only had significant effects on PL but not other Pls-related parameters. Heavy drinkers (more than 3 times per week) showed significantly higher serum concentrations of PL, but there were no significant differences related to the frequency of drinking among groups (data not shown). The proportion of female subjects in the study population (15.4%) was exceedingly low, so the gender comparisons in this study might be limited.
We also determined the serum levels of each molecular species of ether glycerophospholipids (Supplemental Tables IV, V, and VI) and examined their molecular profiles (Figs. 1 and 2 ). Long-chain fatty alcohol species, i.e., hexadecanol (Fig. 1) . However, the biosynthetic route of PlsCho is considered to be derived from PlsEtn, but not from PakCho (20, 21) . As such, the correlation between the serum levels of PlsCho and PlsEtn (r = 0.611, P < 0.01) was higher than that between PlsCho and PakCho (r = 0.521, P < 0.01). The molecular profiles of PlsCho and PlsEtn were remarkably different from each other (Fig.1) , suggesting that a part of serum PlsCho may be 
Relationship between ether glycerophospholipids and risk factors for the atherogenic state
We found that the PlsCho/PL (mol%) was significantly associated with multiple risk factors for the atherogenic status and that these correlations were at similar, or even higher, levels than those of HDL-C ( Table 2 ). In addition, we found (Table 3 ).
In addition, we noticed that the proportion of PlsCho with 18:2 in total serum phospholipids (PlsCho18:2/PL) correlated negatively with age (Fig. 5) . Interestingly, our results also suggest that both classes of Pls with eicosapentaenoic acid (20:5) in sn-2 are associated with the frequency of fish intake (PlsCho, r = 0.373, P < 0.05; PlsEtn, r = 0.273, P < 0.05), whereas total 20:5 lipids in sera exhibited no significant correlation (data not shown).
Of note, the serum levels of both classes of Pls molecular species were found to highly correlate with the serum HDL-C concentration, as described previously (22) .
The comparison of correlation coefficients among various molecular species in the ≥40 male subjects (n = 186) demonstrates that the amount of serum PlsCho with 18:1 in the sn-2 position correlated most strongly with the HDL-C concentration (r = 0.741, P < 0.001; Fig. 6) . Notably, the levels of both classes of Pls with docosapentaenoic acid (22:5) or 22:6 in sn-2 were also found to be associated with the HDL-C levels. 
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DISCUSSION
Here, we report for the first time that the PlsCho/PL (mol%) not only was significantly lower in the ≥40 male group (Table 1) but also showed stronger correlations with multiple antiatherogenic parameters than HDL-C ( Table 2 ). In Choline glycerophospholipids are synthesized in the liver via two major pathways, i.e., the CDP-choline and phosphatidylethanolamine (PE) methylation pathways, and the latter is catalyzed by the hepatocyte-specific enzyme phosphatidylethanolamine N-methyltransferase (PEMT) through three steps during reaction with
S-adenosylmethionine (25).
The CDP-choline pathway is the dominant route for ChoGpl synthesis in all mammalian tissues, while the PEMT methylation pathway is responsible for ~30% of ChoGpl generated in the liver. Given that PlsCho are principally synthesized via PlsEtn, a part of plasma PlsCho may be generated through hepatic PEMT methylation pathway (26). Interestingly, a polymorphism of the human PEMT gene is associated with diminished activity and may confer susceptibility to non-alcoholic fatty liver Columns represent results from a Spearman's correlation coefficient by rank test for over 40 year old male subjects (n = 186). Dashed lines indicate the r value of 0.18, which is taken to be statistically significant with P < 0.01. Identification and quantification of individual ether glycerophospholipid molecular species were performed with the method as described in the Materials and Methods.
TABLES
Diacylglycerophospholipid molecular species were identified using the mass fragments same as used for identification of alkylphospholipid molecular species. 
